Tautomycetin suppresses the TNFalpha/NF-kappaB pathway via inhibition of IKK activation

Shinya Mitsuhashi1, Hiroshi Shima, Ying Li

  • 1Division of Biochemical Oncology and Immunology, Institute for Genetic Medicine, Hokkaido University, Kita-ku, Sapporo 060-0815, Japan.

Insights

Tautomycetin (TC) inhibits the Tumor Necrosis Factor-alpha (TNFalpha)-induced Nuclear Factor-kappaB (NF-kappaB) pathway by targeting IKK activation. This suggests TC as a potential therapeutic to suppress cancer-promoting signaling.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Tumor Necrosis Factor-alpha (TNFalpha) signaling activates Nuclear Factor-kappaB (NF-kappaB), a key pathway implicated in various hematological and solid tumors.
  • Inhibitor of kappaB kinase (IKK) is a critical regulator in the TNFalpha-NF-kappaB pathway.

Purpose of the Study:

  • To investigate the specific inhibitory effects of tautomycetin (TC) on TNFalpha-induced NF-kappaB activation.
  • To elucidate the molecular mechanism by which TC modulates the NF-kappaB pathway.

Main Methods:

  • Treatment with tautomycetin (TC) to assess its effect on NF-kappaB activation.
  • Analysis of T-loop phosphorylation of IKKalpha and IKKbeta.
  • Co-immunoprecipitation and pull-down assays to identify protein interactions within the TNFalpha signaling complex.

Main Results:

  • Tautomycetin (TC) specifically inhibited NF-kappaB activation among TNFalpha effectors (NF-kappaB, JNK, caspase).
  • TC blocked T-loop phosphorylation of IKKalpha and IKKbeta, preventing IkappaBalpha degradation.
  • Protein phosphatase 1 catalytic subunit (PP1C) was identified as part of the IKK complex and recruited to TNFR1, positively regulating TNFalpha-induced NF-kappaB activation.

Conclusions:

  • Protein phosphatase 1 (PP1) positively regulates TNFalpha-induced NF-kappaB pathway activation at the IKK level.
  • Tautomycetin (TC) demonstrates therapeutic potential for suppressing the TNFalpha/NF-kappaB pathway in malignancies.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...